BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16865689)

  • 1. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Kuick R; Misek DE; Youkilis AS; Wechsler DS; Sommer C; Reifenberger G; Hanash SM
    Am J Pathol; 2003 Sep; 163(3):1033-43. PubMed ID: 12937144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas.
    Waha A; Güntner S; Huang TH; Yan PS; Arslan B; Pietsch T; Wiestler OD; Waha A
    Neoplasia; 2005 Mar; 7(3):193-9. PubMed ID: 15799819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent epigenetic inactivation of the chaperone SGNE1/7B2 in human gliomas.
    Waha A; Felsberg J; Hartmann W; Hammes J; von dem Knesebeck A; Endl E; Pietsch T; Waha A
    Int J Cancer; 2012 Aug; 131(3):612-22. PubMed ID: 21901745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
    Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
    Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma.
    Foltz G; Ryu GY; Yoon JG; Nelson T; Fahey J; Frakes A; Lee H; Field L; Zander K; Sibenaller Z; Ryken TC; Vibhakar R; Hood L; Madan A
    Cancer Res; 2006 Jul; 66(13):6665-74. PubMed ID: 16818640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas.
    Götze S; Wolter M; Reifenberger G; Müller O; Sievers S
    Int J Cancer; 2010 Jun; 126(11):2584-93. PubMed ID: 19847810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma malignancy is linked to interdependent and inverse AMOG and L1 adhesion molecule expression.
    Jiang Q; Xie Q; Hu C; Yang Z; Huang P; Shen H; Schachner M; Zhao W
    BMC Cancer; 2019 Sep; 19(1):911. PubMed ID: 31510944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
    Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTB and SDHA Are Suitable Endogenous Reference Genes for Gene Expression Studies in Human Astrocytomas Using Quantitative RT-PCR.
    Röhn G; Koch A; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802318. PubMed ID: 30259794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genes for the progression of malignant gliomas identified by microarray analysis.
    Bozinov O; Köhler S; Samans B; Benes L; Miller D; Ritter M; Sure U; Bertalanffy H
    Neurosurg Rev; 2008 Jan; 31(1):83-9; discussion 89-90. PubMed ID: 17917751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the prion-like protein doppel gene (PRND) in astrocytomas: a new molecular marker potentially involved in tumor progression.
    Comincini S; Facoetti A; Del Vecchio I; Peoc'h K; Laplanche JL; Magrassi L; Ceroni M; Ferretti L; Nano R
    Anticancer Res; 2004; 24(3a):1507-17. PubMed ID: 15274317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMOG/beta2 and glioma invasion: does loss of AMOG make tumour cells run amok?
    Senner V; Schmidtpeter S; Braune S; Püttmann S; Thanos S; Bartsch U; Schachner M; Paulus W
    Neuropathol Appl Neurobiol; 2003 Aug; 29(4):370-7. PubMed ID: 12887597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of multiple genes in astrocytic gliomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
    Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.